GB2114573B - Stabilized insulin solutions and methods for their production - Google Patents

Stabilized insulin solutions and methods for their production

Info

Publication number
GB2114573B
GB2114573B GB08303133A GB8303133A GB2114573B GB 2114573 B GB2114573 B GB 2114573B GB 08303133 A GB08303133 A GB 08303133A GB 8303133 A GB8303133 A GB 8303133A GB 2114573 B GB2114573 B GB 2114573B
Authority
GB
United Kingdom
Prior art keywords
production
methods
insulin solutions
stabilized insulin
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08303133A
Other languages
English (en)
Other versions
GB2114573A (en
GB8303133D0 (en
Inventor
Jens Jorgen Vejlgaard Brange
Svend Havelund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Industri AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri AS filed Critical Novo Industri AS
Publication of GB8303133D0 publication Critical patent/GB8303133D0/en
Publication of GB2114573A publication Critical patent/GB2114573A/en
Application granted granted Critical
Publication of GB2114573B publication Critical patent/GB2114573B/en
Expired legal-status Critical Current

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K13/00—Apparatus or processes specially adapted for manufacturing or adjusting assemblages of electric components
    • H05K13/06—Wiring by machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB08303133A 1982-02-05 1983-02-04 Stabilized insulin solutions and methods for their production Expired GB2114573B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK49182 1982-02-05

Publications (3)

Publication Number Publication Date
GB8303133D0 GB8303133D0 (en) 1983-03-09
GB2114573A GB2114573A (en) 1983-08-24
GB2114573B true GB2114573B (en) 1985-05-01

Family

ID=8094159

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08303133A Expired GB2114573B (en) 1982-02-05 1983-02-04 Stabilized insulin solutions and methods for their production

Country Status (22)

Country Link
US (1) US4476118A (enExample)
JP (1) JPS58192818A (enExample)
AT (1) AT382780B (enExample)
AU (1) AU549981B2 (enExample)
BE (1) BE895832A (enExample)
CA (1) CA1203476A (enExample)
CH (1) CH657530A5 (enExample)
DE (1) DE3303860A1 (enExample)
ES (1) ES519533A0 (enExample)
FI (1) FI78616C (enExample)
FR (1) FR2521009B1 (enExample)
GB (1) GB2114573B (enExample)
GR (1) GR77388B (enExample)
IE (1) IE54548B1 (enExample)
IT (1) IT1178455B (enExample)
LU (1) LU84632A1 (enExample)
NL (1) NL187269C (enExample)
NO (1) NO161204C (enExample)
NZ (1) NZ203189A (enExample)
PT (1) PT76195B (enExample)
SE (1) SE460948B (enExample)
ZA (1) ZA83742B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
JP4307550B2 (ja) * 1995-11-13 2009-08-05 メドトロニック ミニメッド、 インコーポレイティド 単量体状タンパク質の送達のための方法及び組成物
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
EP0821006B1 (de) * 1996-07-26 2004-04-21 Aventis Pharma Deutschland GmbH Insulinderivate mit erhöhter Zinkbindung
SI0884053T1 (en) * 1997-06-13 2003-02-28 Eli Lilly And Company Stable insulin formulations
AR012894A1 (es) * 1997-06-13 2000-11-22 Lilly Co Eli Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
WO1999024071A1 (en) * 1997-11-12 1999-05-20 Alza Corporation Method for decreasing self-association of polypeptides
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
RU2218935C2 (ru) * 1998-10-16 2003-12-20 Ново Нордиск А/С Стабильные концентрированные препаративные формы инсулина для доставки через легкие
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
US6689747B2 (en) * 2000-03-24 2004-02-10 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
JP5599543B2 (ja) 2002-05-07 2014-10-01 ノヴォ ノルディスク アー／エス 単量体インスリン及びアシル化インスリンを含む可溶性製剤
US20050065066A1 (en) * 2002-12-20 2005-03-24 Kaarsholm Niels Christian Stabilised insulin compositions
WO2004056347A2 (en) * 2002-12-20 2004-07-08 Novo Nordisk A/S Pharmaceutical compositions comprising insulin and legends of insulin hexamer
WO2004096266A1 (en) * 2003-05-02 2004-11-11 Novo Nordisk A/S Improved physical stability of insulin formulations
EP2264065B1 (en) * 2003-08-05 2017-03-08 Novo Nordisk A/S Novel insulin derivatives
EP2626368B1 (en) * 2004-07-19 2016-12-21 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
EP1969004B1 (en) 2005-12-28 2011-08-10 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
US20090136538A1 (en) * 2006-05-22 2009-05-28 Jan Jezek Stable vaccine formulation
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
EP2134351B1 (en) 2007-03-13 2016-04-27 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
JP5552046B2 (ja) * 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー／エス インスリン誘導体を含有する薬学的製剤
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
PT2597103T (pt) * 2007-11-16 2017-02-08 Novo Nordisk As Composições farmacêuticas contendo insulina e um péptido insulinotrófico
EP2328607A1 (en) * 2008-07-16 2011-06-08 Arecor Limited Stable formulation of a therapeutic protein
EP2341940A1 (en) * 2008-07-16 2011-07-13 Arecor Limited The stabilisation of proteins
WO2010049488A1 (en) * 2008-10-30 2010-05-06 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
DK2632478T3 (da) 2010-10-27 2019-10-07 Novo Nordisk As Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
US8933022B2 (en) 2011-03-01 2015-01-13 Jds Therapeutics, Llc Methods and compositions for the treatment and prevention Hypoglycemia and related disorders
WO2014076423A1 (fr) 2012-11-13 2014-05-22 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
NZ707160A (en) 2012-12-19 2016-08-26 Wockhardt Ltd A stable aqueous composition comprising human insulin or an analogue or derivative thereof
NZ707168A (en) 2012-12-26 2016-09-30 Wockhardt Ltd Pharmaceutical composition of insulins
TWI780236B (zh) * 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
EP3077414B1 (en) * 2013-12-04 2020-06-17 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
TW201630622A (zh) 2014-12-16 2016-09-01 美國禮來大藥廠 速效胰島素組合物
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
EP3413900A1 (en) 2016-02-11 2018-12-19 Nutrition 21, LLC Chromium containing compositions for improving health and fitness
CN109803639B (zh) * 2016-09-29 2024-01-02 艾瑞克有限公司 新制剂
EP3630166B1 (en) 2017-06-01 2022-04-06 Eli Lilly and Company Rapid-acting insulin compositions
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
CN120142500B (zh) * 2025-02-28 2025-10-10 中国计量科学研究院 一种具有互换性的活性人胰岛素溶液标准物质及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882202A (en) * 1950-04-05 1959-04-14 Novo Terapeutisk Labor As Insulin crystal preparations and methods of producing them
US2787575A (en) * 1950-11-22 1957-04-02 Organon Zinc-glycine-insulin composition and production thereof
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
DE1044360B (de) * 1953-08-19 1958-11-20 Roskilde Medical Company Ltd R Verfahren zur Herstellung von Zinkinsulin mit erhoehtem Zinkgehalt
DE956098C (de) * 1954-02-18 1957-01-10 Dr Dr Guenther Weitzel Verfahren zur Herstellung zinkreicher Insulin-Komplexverbindungen
US3058885A (en) * 1957-06-08 1962-10-16 Novo Terapeutisk Labor As Process for treatment of insulin crystals and for production of insulin preparationstherefrom
US3014842A (en) * 1957-08-10 1961-12-26 Novo Terapeutish Lab A S Injectable bovine insulin crystal suspensions and process of producing same
US3091573A (en) * 1958-05-12 1963-05-28 Novo Terapeutisk Labor As Quick acting insulin preparation
FR1263220A (fr) * 1958-08-01 1961-06-09 Novo Terapeutisk Labor As Procédé de production d'une préparation d'insuline à action rapide
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3657425A (en) * 1969-03-12 1972-04-18 Burroughs Wellcome Co Beef insulin preparations
DE2459515C3 (de) * 1974-12-17 1982-02-11 Hoechst Ag, 6000 Frankfurt Arzneimittelzubereitungen mit antidiabetischer Wirkung
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DK80781A (da) * 1980-02-29 1981-08-30 Hospital For Sick Children Oploesninger af polypeptider
WO1983003054A1 (en) * 1982-03-03 1983-09-15 Johansen, Kristian, Betton A proces for producing an insulin preparation

Also Published As

Publication number Publication date
SE8300598L (sv) 1983-08-06
GR77388B (enExample) 1984-09-11
ZA83742B (en) 1983-11-30
FR2521009A1 (fr) 1983-08-12
DE3303860A1 (de) 1983-08-18
PT76195A (en) 1983-03-01
AT382780B (de) 1987-04-10
IT8319420A0 (it) 1983-02-04
IE830220L (en) 1983-08-05
LU84632A1 (fr) 1983-09-08
BE895832A (fr) 1983-08-04
JPH0367056B2 (enExample) 1991-10-21
NL8300440A (nl) 1983-09-01
GB2114573A (en) 1983-08-24
NO161204C (no) 1989-07-19
DE3303860C2 (enExample) 1989-12-28
FI830375L (fi) 1983-08-06
AU549981B2 (en) 1986-02-20
NZ203189A (en) 1985-07-31
ATA38983A (de) 1986-09-15
NO161204B (no) 1989-04-10
PT76195B (en) 1986-01-27
JPS58192818A (ja) 1983-11-10
GB8303133D0 (en) 1983-03-09
FI78616C (fi) 1989-09-11
SE460948B (sv) 1989-12-11
NO830385L (no) 1983-08-08
NL187269B (nl) 1991-03-01
ES8500060A1 (es) 1984-10-16
CH657530A5 (de) 1986-09-15
CA1203476A (en) 1986-04-22
FR2521009B1 (fr) 1987-07-17
AU1113683A (en) 1983-08-11
NL187269C (nl) 1991-08-01
FI830375A0 (fi) 1983-02-03
IT1178455B (it) 1987-09-09
SE8300598D0 (sv) 1983-02-04
IE54548B1 (en) 1989-11-08
US4476118A (en) 1984-10-09
FI78616B (fi) 1989-05-31
ES519533A0 (es) 1984-10-16

Similar Documents

Publication Publication Date Title
GB2114573B (en) Stabilized insulin solutions and methods for their production
PT75766A (en) Process for preparing stabilized insulin solutions
ZA848273B (en) Armour-plate and process for its manufacture
DE3369710D1 (en) Improved polyester fiber and method for the production thereof
DE3171273D1 (en) Immunoparticles and process for preparing the same
DE3461249D1 (en) Improved trachea cannula
DE3479069D1 (en) Battery and process for its production
ZA814606B (en) New benzisoselenazolones process for producing the same and pharmaceutical preparations containing the same
DE3364804D1 (en) Polyamide membrane and process for its production
YU135784A (en) Process for making dihydroimidazopyrolopyridine and hinoline, tieno-dihydrotieno-furo-i dihydrofuroimidazopyrolopyridine
EP0155852A3 (en) Thrombin-binding substance and process for its productiothrombin-binding substance and process for its production n
DE3480197D1 (en) 5-alkylidene-2-halo-4-substituted-2-cyclopentenone and process for production thereof
GB2124827B (en) Thermistor- bolometer and method for the manufacture thereof
PT73026B (en) Process for preparing carbapenams and carbapen-2-ems
DE3366378D1 (en) Novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and methods for their production
DE3573127D1 (en) Polyamide film and process for its production
DE3261810D1 (en) Alkoxyaminohydridosilanes and process for producing them
IL67451A0 (en) 4-cyano-2-azetidinones and production thereof
EP0072931A3 (en) Package and method for its production
GB2127024B (en) Modified proteins and process for the production thereof
DE3071273D1 (en) Disoxidant and process for preparing same
PT76355B (en) Isoxazolopyrimidine derivatives and production thereof
DE3169906D1 (en) 17-beta-ethynylsteroids and process for preparing same
DE3161030D1 (en) 1-hydroxypyrazole and process for preparing the same
ZA821243B (en) Stabilized insulin preparation and method for their production

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20030203